HCA
TMO icon

Harbour Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Harbour Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88M Buy
7,355
+4
+0.1% +$1.92K 0.71% 36
2026
Q1 		$3.78M Buy
7,351
+74
+1% +$40.2K 0.72% 36
2025
Q4 		$4.31M Buy
7,277
+15
+0.2% +$8.48K 0.88% 31
2025
Q3 		$3.92M Sell
7,262
-128
-2% -$59.6K 0.8% 35
2025
Q2 		$3.16M Sell
7,390
-55
-0.7% -$23K 0.67% 44
2025
Q1 		$3.5M Sell
7,445
-55
-0.7% -$29.8K 0.87% 30
2024
Q4 		$3.99M Sell
7,500
-21
-0.3% -$11.5K 0.89% 31
2024
Q3 		$4.51M Buy
7,521
+48
+0.6% +$28.4K 1.04% 28
2024
Q2 		$4.05M Buy
7,473
+26
+0.3% +$14.9K 0.96% 29
2024
Q1 		$4.26M Buy
7,447
+64
+0.9% +$35.9K 1.05% 25
2023
Q4 		$3.9M Buy
7,383
+18
+0.2% +$8.71K 1.07% 26
2023
Q3 		$3.73M Buy
7,365
+55
+0.8% +$29.3K 1.12% 23
2023
Q2 		$3.79M Sell
7,310
-78
-1% -$42.1K 1.12% 24
2023
Q1 		$4.26M Buy
7,388
+62
+0.8% +$34.9K 1.29% 20
2022
Q4 		$4.05M Sell
7,326
-658
-8% -$349K 1.36% 19
2022
Q3 		$4.08M Buy
7,984
+13
+0.2% +$7.28K 1.41% 19
2022
Q2 		$4.33M Buy
7,971
+40
+0.5% +$22K 1.41% 18
2022
Q1 		$4.68M Buy
7,931
+41
+0.5% +$23.6K 1.28% 21
2021
Q4 		$5.26M Buy
7,890
+7
+0.1% +$4.37K 1.29% 19
2021
Q3 		$4.5M Buy
7,883
+45
+0.6% +$24.7K 1.19% 22
2021
Q2 		$3.95M Buy
7,838
+96
+1% +$45.3K 1.06% 27
2021
Q1 		$3.53M Buy
+7,742
New +$3.7M 1.04% 27
2020
Q4 		– Sell
-7,707
Closed -$3.4M – 173
2020
Q3 		$3.4M Sell
7,707
-38
-0.5% -$15.7K 1.24% 23
2020
Q2 		$2.81M Sell
7,745
-34
-0.4% -$11.4K 1.14% 24
2020
Q1 		$2.21M Buy
7,779
+43
+0.6% +$13.6K 1.12% 27
2019
Q4 		$2.51M Buy
7,736
+98
+1% +$29.7K 0.96% 31
2019
Q3 		$2.23M Buy
7,638
+342
+5% +$97.9K 0.94% 31
2019
Q2 		$2.14M Buy
7,296
+248
+4% +$68.3K 0.92% 29
2019
Q1 		$1.93M Sell
7,048
-11
-0.2% -$2.74K 0.85% 35
2018
Q4 		$1.58M Buy
7,059
+2
+0% +$469 0.78% 39
2018
Q3 		$1.72M Sell
7,057
-195
-3% -$44.9K 0.69% 40
2018
Q2 		$1.49M Buy
7,252
+56
+0.8% +$11.9K 0.64% 48
2018
Q1 		$1.49M Sell
7,196
-217
-3% -$45.5K 0.63% 49
2017
Q4 		$1.41M Buy
7,413
+395
+6% +$75.7K 0.58% 54
2017
Q3 		$1.33M Buy
7,018
+134
+2% +$24.3K 0.58% 45
2017
Q2 		$1.2M Buy
6,884
+320
+5% +$53.8K 0.6% 52
2017
Q1 		$1.01M Buy
+6,564
New +$1M 0.46% 71
2016
Q3 		– Sell
-4,600
Closed -$680K – 276
2016
Q2 		$680K Hold
4,600
– – 0.38% 93
2016
Q1 		$651K Buy
4,600
+2,590
+129% +$347K 0.37% 99
2015
Q4 		$285K Buy
+2,010
New +$268K 0.16% 188
2014
Q1 		– Sell
-4,718
Closed -$525K – 200
2013
Q4 		$525K Buy
4,718
+600
+15% +$59.7K 0.46% 84
2013
Q3 		$379K Sell
4,118
-920
-18% -$83.2K 0.41% 103
2013
Q2 		$426K Buy
+5,038
New +$419K 0.54% 78

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Harbour Capital Advisors's TMO Position: Q2 2026 in Review

Harbour Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 0.05% in Q2 2026, buying an estimated $1.92K and bringing the position to 7,355 shares worth $3.88M. The position accounts for 0.71% of the portfolio, ranked #36.

Harbour Capital Advisors first reported a position in TMO in Q2 2013 and has held it in 43 quarters since. The position peaked at $5.26M in Q4 2021. 627 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Harbour Capital Advisors held 7,355 shares of Thermo Fisher Scientific worth $3.88M as of Q2 2026.
  • Harbour Capital Advisors bought 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
  • Thermo Fisher Scientific made up 0.71% of Harbour Capital Advisors's portfolio in Q2 2026, its #36 holding.
  • Harbour Capital Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 43 quarters since.
  • Harbour Capital Advisors's Thermo Fisher Scientific position peaked at $5.26M in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.